Medicare Enrolled
Dr. Jermaine Jackson, MD
Pulmonary Disease · Atlanta, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Jackson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jackson?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jackson
Dr. Jermaine Jackson is a pulmonary disease specialist in Atlanta, GA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Jackson performed 1,096 Medicare services across 781 unique beneficiaries.
Between the years covered by Open Payments, Dr. Jackson received a total of $5,343 from 42 pharmaceutical and/or device companies across 306 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jackson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 42% volume in GA
$5,343 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,096
Medicare services
Top 42% in GA for pulmonary disease
781
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~61 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
211 | $132 | $496 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
188 | $95 | $355 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
120 | $1 | $6 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
89 | $13 | $55 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
74 | $20 | $121 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
66 | $42 | $189 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
51 | $25 | $117 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
46 | $42 | $184 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
46 | $134 | $691 |
| New patient office visit, complex (60-74 min) | 36 | $173 | $705 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
35 | $14 | $69 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
27 | $50 | $423 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
21 | $92 | $366 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
18 | $13 | $58 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
16 | $11 | $69 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $89 | $370 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
14 | $31 | $203 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
12 | $31 | $57 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
11 | $72 | $219 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,343
Total received (2018-2024)
Avg $763/year across 7 years
Top 32% in GA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
306
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,330 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,475
2023
$1,113
2022
$484
2021
$637
2020
$357
2019
$713
2018
$564
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$338
GlaxoSmithKline, LLC.
$267
JAZZ PHARMACEUTICALS INC.
$179
GENZYME CORPORATION
$133
Grifols USA, LLC
$87
Regeneron Healthcare Solutions, Inc.
$78
ANI Pharmaceuticals, Inc.
$68
Amgen Inc.
$68
Merck Sharp & Dohme LLC
$45
Actelion Pharmaceuticals US, Inc.
$34
Inspire Medical Systems, Inc.
$28
Mylan Specialty L.P.
$28
Insmed, Inc.
$25
Bayer Healthcare Pharmaceuticals Inc.
$24
Philips North America LLC
$21
Mallinckrodt Hospital Products Inc.
$21
PFIZER INC.
$18
Resmed Corp
$17
Top 3 companies account for 53.1% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,059
AstraZeneca Pharmaceuticals LP
$1,058
Boehringer Ingelheim Pharmaceuticals, Inc.
$379
JAZZ PHARMACEUTICALS INC.
$258
GENZYME CORPORATION
$213
Grifols USA, LLC
$204
ANI Pharmaceuticals, Inc.
$199
Insmed, Inc.
$174
Regeneron Healthcare Solutions, Inc.
$150
Mallinckrodt Hospital Products Inc.
$146
Teva Pharmaceuticals USA, Inc.
$143
Mylan Specialty L.P.
$137
PFIZER INC.
$128
Actelion Pharmaceuticals US, Inc.
$93
Amgen Inc.
$87
Merck Sharp & Dohme LLC
$86
Takeda Pharmaceuticals U.S.A., Inc.
$76
Mallinckrodt Enterprises LLC
$68
Janssen Pharmaceuticals, Inc
$61
Bayer HealthCare Pharmaceuticals Inc.
$60
United Therapeutics Corporation
$59
Gilead Sciences, Inc.
$45
Mallinckrodt LLC
$43
Bayer Healthcare Pharmaceuticals Inc.
$41
Theravance Biopharma, Inc.
$40
Covis Pharma GmBH
$34
Resmed Corp
$30
Inspire Medical Systems, Inc.
$28
Vapotherm Inc
$27
Novartis Pharmaceuticals Corporation
$24
PORTOLA PHARMACEUTICALS, INC.
$22
Shire North American Group Inc
$21
Philips North America LLC
$21
Optinose US, Inc.
$17
Philips Electronics North America Corporation
$16
Otsuka America Pharmaceutical, Inc.
$16
Alexion Pharmaceuticals, Inc.
$16
La Jolla Pharmaceutical Company
$14
Genentech USA, Inc.
$14
Sandoz Inc.
$13
Chiesi USA, Inc.
$12
E.R. Squibb & Sons, L.L.C.
$12
Top 3 companies account for 46.7% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIR 11 · AIRSENSE · ALVESCO · ANORO · ANORO ELLIPTA · AREXVY · Adempas · AirDuo Digihaler · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREZTRI · CINQAIR · CLEVIPREX · CUTAQUIG · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · ELIQUIS · EVUSHELD · FASENRA · GIAPREZA · GLASSIA · IMFINZI · INSPIRE · NUCALA · OFEV · OPSUMIT · PREVNAR - 13 · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Prolastin-C Liquid · SAMSCA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TREPROSTINIL · TYVASO · ULTOMIRIS · VIBATIV · WINREVAIR · XARELTO · XOLAIR · XYWAV · Xembify · Xhance · Xolair · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
136
Per 100K population
12.7
County median income
$91,490
Nearest hospital
PIEDMONT HOSPITAL, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Jackson is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Jackson experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Jackson performed 211 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jackson receive payments from pharmaceutical companies?
Yes. Dr. Jackson received a total of $5,343 from 42 companies across 306 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jackson's costs compare to other pulmonary diseases in Atlanta?
Dr. Jackson's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jackson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Atlanta
Browse pulmonary diseases in Atlanta ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in GA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in GA
Which GA pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology